Sort by
Items per page

Send to

Choose Destination

Best matches for cannabinoid cancer:

Cannabis in cancer care. Abrams DI et al. Clin Pharmacol Ther. (2015)

Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. Murase R et al. Br J Pharmacol. (2014)

Medical marijuana for cancer. Kramer JL et al. CA Cancer J Clin. (2015)

Search results

Items: 1 to 20 of 1529


Inhibition of Diacylglycerol Lipase Impairs Fear Extinction in Mice.

Cavener VS, Gaulden A, Pennipede D, Jagasia P, Uddin J, Marnett LJ, Patel S.

Front Neurosci. 2018 Jul 31;12:479. doi: 10.3389/fnins.2018.00479. eCollection 2018.


Inhibition and stimulation of the human breast cancer resistance protein as in vitro predictor of drug-drug interactions of drugs of abuse.

Wagmann L, Maurer HH, Meyer MR.

Arch Toxicol. 2018 Aug 6. doi: 10.1007/s00204-018-2276-y. [Epub ahead of print]


Cannabinoid pharmacology and therapy in gut disorders.

Uranga JA, Vera G, Abalo R.

Biochem Pharmacol. 2018 Aug 2. pii: S0006-2952(18)30318-6. doi: 10.1016/j.bcp.2018.07.048. [Epub ahead of print] Review.


Cannabinoid Receptor-1 Up-regulation in Azoxymethane (AOM)-treated Mice After Dietary Treatment with Quercetin.

Tutino V, DE Nunzio V, Tafaro A, Bianco G, Gigante I, Scavo MP, D'Alessandro R, Refolo MG, Messa C, Caruso MG, Notarnicola M.

Anticancer Res. 2018 Aug;38(8):4485-4491. doi: 10.21873/anticanres.12752.


Chronic pain and cannabinoids. Great expectations or a christmas carol.

Pascual D, Sánchez-Robles EM, García MM, Goicoechea C.

Biochem Pharmacol. 2018 Jul 27. pii: S0006-2952(18)30301-0. doi: 10.1016/j.bcp.2018.07.033. [Epub ahead of print] Review.


Emerging strategies targeting CB2 cannabinoid receptor: Biased agonism and allosterism.

Morales P, Goya P, Jagerovic N.

Biochem Pharmacol. 2018 Jul 26. pii: S0006-2952(18)30299-5. doi: 10.1016/j.bcp.2018.07.031. [Epub ahead of print] Review.


Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review.

Polito S, MacDonald T, Romanick M, Jupp J, Wiernikowski J, Vennettilli A, Khanna M, Patel P, Ning W, Sung L, Dupuis LL.

Pediatr Blood Cancer. 2018 Jul 26:e27374. doi: 10.1002/pbc.27374. [Epub ahead of print]


Therapeutic applications of cannabinoids.

Maurya N, Velmurugan BK.

Chem Biol Interact. 2018 Jul 21;293:77-88. doi: 10.1016/j.cbi.2018.07.018. [Epub ahead of print] Review.


Anti-tumour actions of cannabinoids.

Hinz B, Ramer R.

Br J Pharmacol. 2018 Jul 17. doi: 10.1111/bph.14426. [Epub ahead of print] Review.


Marijuana Use in Adults Living with Sickle Cell Disease.

Roberts JD, Spodick J, Cole J, Bozzo J, Curtis S, Forray A.

Cannabis Cannabinoid Res. 2018 Jul 1;3(1):162-165. doi: 10.1089/can.2018.0001. eCollection 2018.


Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines.

Sultan AS, Marie MA, Sheweita SA.

Breast. 2018 Jun 22;41:34-41. doi: 10.1016/j.breast.2018.06.009. [Epub ahead of print]


Molecular Imaging of Pancreatic Duct Adenocarcinoma Using a Type 2 Cannabinoid Receptor-Targeted Near-Infrared Fluorescent Probe.

Guo X, Ling X, Du F, Wang Q, Huang W, Wang Z, Ding X, Bai M, Wu Z.

Transl Oncol. 2018 Jul 9;11(5):1065-1073. doi: 10.1016/j.tranon.2018.06.009. [Epub ahead of print]


Identification of Synergistic Interaction Between Cannabis-Derived Compounds for Cytotoxic Activity in Colorectal Cancer Cell Lines and Colon Polyps That Induces Apoptosis-Related Cell Death and Distinct Gene Expression.

Nallathambi R, Mazuz M, Namdar D, Shik M, Namintzer D, Vinayaka AC, Ion A, Faigenboim A, Nasser A, Laish I, Konikoff FM, Koltai H.

Cannabis Cannabinoid Res. 2018 Jun 1;3(1):120-135. doi: 10.1089/can.2018.0010. eCollection 2018.


Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief.

Gado F, Di Cesare Mannelli L, Lucarini E, Bertini S, Cappelli E, Digiacomo M, Stevenson LA, Macchia M, Tuccinardi T, Ghelardini C, Pertwee RG, Manera C.

J Med Chem. 2018 Jul 23. doi: 10.1021/acs.jmedchem.8b00368. [Epub ahead of print]


Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation.

Mulpuri Y, Marty VN, Munier JJ, Mackie K, Schmidt BL, Seltzman HH, Spigelman I.

Neuropharmacology. 2018 Sep 1;139:85-97. doi: 10.1016/j.neuropharm.2018.07.002. Epub 2018 Jul 5.


Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.

Campbell G, Hall WD, Peacock A, Lintzeris N, Bruno R, Larance B, Nielsen S, Cohen M, Chan G, Mattick RP, Blyth F, Shanahan M, Dobbins T, Farrell M, Degenhardt L.

Lancet Public Health. 2018 Jul;3(7):e341-e350. doi: 10.1016/S2468-2667(18)30110-5.


Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells.

Capozzi A, Mattei V, Martellucci S, Manganelli V, Saccomanni G, Garofalo T, Sorice M, Manera C, Misasi R.

Int J Mol Sci. 2018 Jul 4;19(7). pii: E1958. doi: 10.3390/ijms19071958.


Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey.

Karanges EA, Suraev A, Elias N, Manocha R, McGregor IS.

BMJ Open. 2018 Jul 3;8(7):e022101. doi: 10.1136/bmjopen-2018-022101.


Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression.

Xiang W, Shi R, Kang X, Zhang X, Chen P, Zhang L, Hou A, Wang R, Zhao Y, Zhao K, Liu Y, Ma Y, Luo H, Shang S, Zhang J, He F, Yu S, Gan L, Shi C, Li Y, Yang W, Liang H, Miao H.

Nat Commun. 2018 Jul 3;9(1):2574. doi: 10.1038/s41467-018-04999-8.


Cannabis and Cannabinoids (PDQ®): Health Professional Version.

PDQ Integrative, Alternative, and Complementary Therapies Editorial Board.

PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.
2018 Jun 19.

Supplemental Content

Loading ...
Support Center